ANATE (Amodiaquine 75mg/Artesunate 25mg) PEDIATRIC (BELOW 1 YEAR) x 6 SACHETS

ANATE (Amodiaquine 75mg/Artesunate 25mg) PEDIATRIC (BELOW 1 YEAR) x 6 SACHETS
Generic Name: Amodiaquine/Artesunate
Brand Name: Anate.
Class: Antimalarial
Pack Size: 6 Sachets
Strength: Amodiaquine 75mg/Artesunate 25mg base per tablet
Amount: ₦800.

Description: ANATE Paediatric Sachets offer a potent combination of Amodiaquine and Artesunate, designed specifically for the treatment of uncomplicated malaria in infants under one year. This artemisinin-based combination therapy (ACT) ensures rapid and effective treatment, targeting the malaria parasite Plasmodium falciparum. Each sachet contains a precise dose of Amodiaquine (75mg) and Artesunate (25mg), formulated for ease of administration in young children.

Key Features
• Pediatric Formulation: Tailored dosage for infants under 1 year, ensuring safety and effectiveness.
• Effective Malaria Treatment: Combines Amodiaquine and Artesunate to combat malaria parasites efficiently.
• Convenient Sachets: Easy-to-administer sachets that can be mixed with water or food for simplified dosing.
• WHO Recommended: Adheres to World Health Organization guidelines for the treatment of uncomplicated P. falciparum malaria.

Side Effects
Common side effects may include:
• Mild gastrointestinal discomfort (nausea, vomiting, diarrhoea)
• Dizziness
• Loss of appetite
• Rare but serious side effects (seek medical attention immediately):
Severe allergic reactions (rash, itching, swelling)
• Hepatotoxicity (jaundice, abdominal pain)
• Hematological abnormalities (unusual bleeding or bruising)

Cautions
• Allergy Alert: Do not administer if the child is allergic to Amodiaquine, Artesunate, or any other ingredients in the product.
• Liver and Blood Disorders: Use with caution in children with pre-existing liver or blood disorders. Regular monitoring may be necessary.
• Drug Interactions: Ensure to inform the healthcare provider of any other medications the child is taking to avoid potential interactions.
• Supervision Required: Administer under medical supervision, especially in infants with a history of severe malaria or other serious illnesses.